News & Analysis as of

Agricultural Sector › Intellectual Property Protection › Life Sciences

Jones Day

Physical Products Cannot Form Basis of an IPR

Jones Day on

On May 1, 2025, the Patent Trial and Appeal Board (PTAB) denied institution of inter partes review (IPR) of U.S. Patent No. 11,140,841 in the case of Aardevo North America, LLC v. Agventure B.V. The patent in question, owned...more

Morrison & Foerster LLP

Updates in Uruguay – Accession to the PCT and Announcement of a New GMO Regulatory Framework

Morrison & Foerster LLP on

Earlier this year, Uruguay announced two major updates in the patent and regulatory spheres that are likely to encourage outside investment in Uruguayan industry, particularly for agbiotech: Uruguay is acceding to the Patent...more

Morrison & Foerster LLP

Preparing for Investment (and Success) as an Early-Stage Alternative Protein Business

Morrison & Foerster LLP on

Our last two alerts in this series covered key considerations for early-stage companies in the alternative protein industry and provided an overview of financing in the alternative protein industry. This alert follows those...more

MoFo Life Sciences

IP Implications Of USDA Research Collaborations

MoFo Life Sciences on

Many stakeholders in the AgTech industry are interested in collaborating with or obtaining funding from the United States Department of Agriculture (USDA), but are unsure what implications such collaborations may have on...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide